Effect of diterpenoid alkaloids on cardiac sympathetic efferent and vagal afferent nerve activity.
The diterpenoid alkaloid, lappaconitine, at a dose of 150 micrograms/kg (i.v.) increased cardiac vagal afferent nerve activity (16.2%) and reduced cardiac sympathetic efferent nerve activity (12.5%). A polar analog, N-deacetyllappaconitine, at this same dose, increased cardiac vagal afferent nerve activity (40%) and reduced cardiac sympathetic efferent nerve activity (23.5%). Both of these agents also reduced arterial blood pressure and heart rate. A larger dose of lappaconitine (300 micrograms/kg i.v.) produced the same changes in nerve activities and cardiac function as the lower dose. Two other structurally related agents, lycoctonine and aconine, failed to alter these variables in doses up to 300 micrograms/kg. These data suggest that certain diterpenoid alkaloids activate autonomic reflex receptors, including cardiac reflex receptors. The polar agent, N-deacetyllappaconitine, appears to be more effective on cardiac reflex receptors than the non-polar agent, lappaconitine. Such agents may be useful in the treatment of hypertension.
D000157:Aconitine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000344:Afferent Pathways / Q000187:drug effects*; D000818:Animals; D017776:Autonomic Pathways / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004525:Efferent Pathways / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D013997:Time Factors; D014630:Vagus Nerve / Q000187:drug effects*
D000157:Aconitine; C022150:lappaconitine